Our results were further strengthened by the recent reports wherein PTGFRN was found to be conferring resistance to radiation via PI3K-AKT signaling in GBM [21] and its expression correlated with metastatic capacity in lung cancer [7]. The gene discussed is PTGFRN; the disease is glioblastoma.